Primary |
Hepatitis C |
67.6% |
Drug Use For Unknown Indication |
9.8% |
Hypertension |
3.7% |
Product Used For Unknown Indication |
3.4% |
Chronic Hepatitis C |
2.3% |
Diabetes Mellitus |
1.6% |
Depression |
1.4% |
Hiv Infection |
1.3% |
Anaemia |
1.1% |
Epilepsy |
1.1% |
Pregnancy |
1.1% |
Pain |
0.9% |
Cryoglobulinaemia |
0.7% |
Hepatitis |
0.7% |
Hepatitis C Virus |
0.7% |
Amyotrophic Lateral Sclerosis |
0.5% |
Gastrooesophageal Reflux Disease |
0.5% |
Hypothyroidism |
0.5% |
Insomnia |
0.5% |
Asthma |
0.5% |
|
Anaemia |
10.6% |
Transmission Of Drug Via Semen |
9.9% |
Weight Decreased |
8.6% |
Abortion Spontaneous |
6.0% |
Rash |
6.0% |
Pancytopenia |
5.3% |
Hepatitis |
4.6% |
Sepsis |
4.6% |
Thrombocytopenia |
4.6% |
Vomiting |
4.6% |
Overdose |
4.0% |
Toxic Skin Eruption |
4.0% |
Transaminases Increased |
4.0% |
Delirium |
3.3% |
Haemoglobin Decreased |
3.3% |
Neutropenia |
3.3% |
Photosensitivity Reaction |
3.3% |
Pleural Effusion |
3.3% |
Pregnancy |
3.3% |
Quadriparesis |
3.3% |
|
Secondary |
Hepatitis C |
65.9% |
Chronic Hepatitis C |
6.0% |
Product Used For Unknown Indication |
5.6% |
Drug Use For Unknown Indication |
3.7% |
Hypertension |
3.5% |
Depression |
3.1% |
Hiv Infection |
1.9% |
Anaemia |
1.4% |
Pain |
1.2% |
Hepatic Cirrhosis |
1.0% |
Insomnia |
1.0% |
Prophylaxis |
0.9% |
Anxiety |
0.9% |
Diabetes Mellitus |
0.8% |
Nausea |
0.6% |
Rash |
0.6% |
Thrombocytopenia |
0.5% |
Hepatitis |
0.5% |
Ascites |
0.5% |
Headache |
0.4% |
|
White Blood Cell Count Decreased |
24.2% |
Weight Decreased |
10.5% |
Thrombocytopenia |
7.3% |
Vomiting |
6.8% |
Anaemia |
5.6% |
Rash |
5.1% |
Death |
4.7% |
Weight Increased |
4.7% |
Pancytopenia |
4.6% |
Pyrexia |
4.2% |
Pneumonia |
2.9% |
Syncope |
2.6% |
Pruritus |
2.3% |
Platelet Count Decreased |
2.3% |
Nausea |
2.2% |
Neutropenia |
2.2% |
Urinary Tract Infection |
2.1% |
Renal Failure |
2.0% |
Vision Blurred |
2.0% |
Haemoglobin Decreased |
1.8% |
|
Concomitant |
Hepatitis C |
66.1% |
Product Used For Unknown Indication |
7.0% |
Hypertension |
6.7% |
Hiv Infection |
3.5% |
Diabetes Mellitus |
2.5% |
Chronic Hepatitis C |
2.0% |
Anaemia |
1.8% |
Depression |
1.5% |
Hypothyroidism |
1.1% |
Anxiety |
1.0% |
Urinary Tract Infection |
1.0% |
Prophylaxis |
0.9% |
Sleep Disorder |
0.8% |
Pruritus |
0.7% |
Gastrooesophageal Reflux Disease |
0.6% |
Hepatic Cirrhosis |
0.6% |
Insomnia |
0.6% |
Type 2 Diabetes Mellitus |
0.6% |
Drug Use For Unknown Indication |
0.6% |
Insulin Resistance |
0.6% |
|
Anaemia |
12.3% |
Rash |
10.9% |
Vomiting |
10.0% |
Nausea |
7.9% |
Pruritus |
6.3% |
Drug Rash With Eosinophilia And Systemic Symptoms |
5.4% |
Pyrexia |
5.2% |
Thrombocytopenia |
5.0% |
Asthenia |
4.2% |
Rash Pruritic |
4.2% |
Weight Decreased |
3.6% |
Rash Maculo-papular |
3.3% |
Pancytopenia |
3.1% |
Death |
2.9% |
Inappropriate Schedule Of Drug Administration |
2.9% |
Neutropenia |
2.9% |
Septic Shock |
2.9% |
White Blood Cell Count Decreased |
2.7% |
Drug Eruption |
2.5% |
Fatigue |
2.1% |
|
Interacting |
Hepatitis C |
49.2% |
Product Used For Unknown Indication |
12.7% |
Drug Use For Unknown Indication |
11.9% |
Diabetes Mellitus |
4.8% |
Hepatitis |
4.8% |
Hiv Infection |
4.8% |
Herpes Zoster |
3.2% |
Blood Pressure |
2.4% |
Blood Pressure Increased |
2.4% |
Varicose Vein |
1.6% |
White Blood Cell Count Decreased |
1.6% |
Epilepsy |
0.8% |
|
Vision Blurred |
20.0% |
Weight Decreased |
16.7% |
Drug Interaction |
6.7% |
Liver Function Test Abnormal |
6.7% |
Neutropenia |
6.7% |
Renal Failure Acute |
6.7% |
White Blood Cell Count Decreased |
6.7% |
Epilepsy |
3.3% |
Hallucination, Auditory |
3.3% |
Leg Amputation |
3.3% |
Myocarditis |
3.3% |
Pneumonia |
3.3% |
Prothrombin Time Ratio Decreased |
3.3% |
Stress Cardiomyopathy |
3.3% |
Thrombocytopenia |
3.3% |
Ulcerative Keratitis |
3.3% |
|